Janux Therapeutics Inc (JANX)

Mar 03, 2026

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring The 316.79% Potential Upside - DirectorsTalk Interviews

Mar 03, 2026

Mar 03, 2026

JANX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 03, 2026

Mar 03, 2026

Truist Securities Adjusts PT on Janux Therapeutics to $80 From $100, Maintains Buy Rating - marketscreener.com

Mar 03, 2026

Mar 02, 2026

Janux Therapeutics: Strong Cash Runway, Strategic Bristol-Myers Partnership, and 2026 Clinical Catalysts Underpin Buy Rating - TipRanks

Mar 02, 2026

Mar 02, 2026

Nuvation Bio Inc. (NUVB) Amends Protocol on Safusidenib Trials in Astrocytoma - Bitget

Mar 02, 2026

Mar 02, 2026

Janux Therapeutics, Inc. (JANX) Commences Patient Dosing of JANX011 in Autoimmune Trial - Finviz

Mar 02, 2026

Feb 28, 2026

11 Best Cancer Stocks to Invest In Now - Insider Monkey

Feb 28, 2026

Feb 27, 2026

Janux Therapeutics JANX Net Loss Deepens To US$113.6 Million Challenging Bullish Growth Narratives - simplywall.st

Feb 27, 2026

Feb 27, 2026

Key facts: Janux Therapeutics Receives Strong Buy Ratings; Partners with BMS - TradingView

Feb 27, 2026

Feb 27, 2026

Janux: Encouraging Early T Cell Engager Data, Broad Pipeline, and Strong Cash Runway Support Buy Rating - TipRanks

Feb 27, 2026

Feb 27, 2026

Cantor Fitzgerald Has Lowered Expectations for Janux Therapeutics (NASDAQ:JANX) Stock Price - MarketBeat

Feb 27, 2026

Feb 27, 2026

Guggenheim Has Lowered Expectations for Janux Therapeutics (NASDAQ:JANX) Stock Price - MarketBeat

Feb 27, 2026

Feb 26, 2026

Janux Therapeutics, Inc. Q4 Loss Rises - Nasdaq

Feb 26, 2026

Feb 26, 2026

Janux Therapeutics (NASDAQ:JANX) Releases Quarterly Earnings Results, Beats Expectations By $0.14 EPS - MarketBeat

Feb 26, 2026

Feb 26, 2026

Janux Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Feb 26, 2026

Feb 26, 2026

Janux Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 26, 2026

Feb 26, 2026

Earnings Flash (JANX) Janux Therapeutics, Inc. Reports Q4 Revenue $0 - marketscreener.com

Feb 26, 2026

Feb 26, 2026

Bristol Myers deal and wider 2025 loss at Janux Therapeutics (JANX) - Stock Titan

Feb 26, 2026

Feb 26, 2026

Janux Therapeutics Q4 net loss widens on higher R&D expenses - TradingView

Feb 26, 2026

Feb 26, 2026

BRIEF-Janux Therapeutics Q4 Basic EPS USD -0.51 - TradingView

Feb 26, 2026

Feb 26, 2026

Janux Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights - Business Wire

Feb 26, 2026

Feb 25, 2026

Technical Reactions to JANX Trends in Macro Strategies - Stock Traders Daily

Feb 25, 2026

Feb 24, 2026

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring A 376% Upside In Biotechnology - DirectorsTalk Interviews

Feb 24, 2026

Feb 22, 2026

Janux Therapeutics, Inc. (JANX) faces platform risk amid lack of durability data on JANX007 - MSN

Feb 22, 2026

Feb 19, 2026

Why analysts remain bullish on Janux Therapeutics Inc. stockQuarterly Trade Report & Real-Time Chart Pattern Alerts - mfd.ru

Feb 19, 2026

Feb 19, 2026

Where is Janux Therapeutics (JANX) Headed According to Analysts? - Finviz

Feb 19, 2026

Feb 19, 2026

Janux Therapeutics (JANX) Expected to Announce Earnings on Thursday - MarketBeat

Feb 19, 2026

Feb 17, 2026

Janux therapeutics doses first participant in JANX011 phase 1 trial By Investing.com - Investing.com Australia

Feb 17, 2026

Feb 17, 2026

Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of JANX011 - BioSpace

Feb 17, 2026

Feb 17, 2026

Janux therapeutics doses first participant in JANX011 phase 1 trial - Investing.com Nigeria

Feb 17, 2026

Feb 17, 2026

Janux Therapeutics, Inc. (JANX) Investor Outlook: A Potential 383.93% Upside in the Biotech Sector - DirectorsTalk Interviews

Feb 17, 2026

Feb 17, 2026

Janux Therapeutics Announces First Patient Dosed In Phase 1 Study Of Janx011 - TradingView

Feb 17, 2026

Feb 16, 2026

Wall Street Thinks These 4 Biotech Stocks Will Double–At Least–This Year - AOL.com

Feb 16, 2026

Feb 15, 2026

Published on: 2026-02-15 18:41:23 - mfd.ru

Feb 15, 2026

Feb 14, 2026

Trading the Move, Not the Narrative: (JANX) Edition - Stock Traders Daily

Feb 14, 2026

Feb 11, 2026

Is Janux Therapeutics Inc. forming a bullish divergenceQuarterly Risk Review & Risk Controlled Stock Pick Alerts - mfd.ru

Feb 11, 2026

Feb 11, 2026

What is Janux Therapeutics Inc.’s valuation compared to sectorMarket Performance Recap & Low Drawdown Momentum Trade Ideas - mfd.ru

Feb 11, 2026

Feb 11, 2026

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring a Potential 379% Upside in Biotech Innovations - DirectorsTalk Interviews

Feb 11, 2026

Feb 10, 2026

Breakout Watch: What is Janux Therapeutics Incs debt to equity ratioDividend Hike & Free Safe Capital Growth Stock Tips - baoquankhu1.vn

Feb 10, 2026

Feb 05, 2026

Bristol Myers Squibb Expands RNA And Cell Therapy Pipeline As Valuation Lags - Yahoo! Finance Canada

Feb 05, 2026

Feb 05, 2026

Janux Therapeutics (NASDAQ:JANX) Sets New 52-Week LowShould You Sell? - MarketBeat

Feb 05, 2026

Feb 03, 2026

(JANX) Volatility Zones as Tactical Triggers - Stock Traders Daily

Feb 03, 2026

Feb 03, 2026

Wall Street Analysts See a 319.23% Upside in Janux Therapeutics (JANX): Can the Stock Really Move This High? - Yahoo Finance UK

Feb 03, 2026

Feb 02, 2026

Janux Therapeutics, Inc. (JANX) Faces Platform Risk Amid Lack of Durability Data on JANX007 - Insider Monkey

Feb 02, 2026

Feb 02, 2026

Analysts Bullish Ahead of Colorectal Cancer Readout for CytomX Therapeutics, Inc. (CTMX) - Yahoo Finance

Feb 02, 2026

Feb 01, 2026

Janux Therapeutics, Inc. (NASDAQ:JANX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Feb 01, 2026

Jan 31, 2026

Bristol-Myers Squibb Expands Cancer Efforts With New AI And Drug Deals - Yahoo Finance UK

Jan 31, 2026

Jan 31, 2026

Why is Janux Therapeutics Inc. stock going downPortfolio Value Report & Weekly High Conviction Trade Ideas - mfd.ru

Jan 31, 2026

Jan 30, 2026

Will BMY's Oncology Collaborations Drive Its Next Growth Phase? - The Globe and Mail

Jan 30, 2026

Jan 30, 2026

Janux Therapeutics Repeat Insider Selling Not A Positive Indicator - simplywall.st

Jan 30, 2026